The objective of the present study was to evaluate the serum viral load in chronically infected Hepatitis B virus (HBV) patients and to investigate the distribution of HBV genotypes in São Paulo city. Quantitative HBV-DNA assays and HBV genotyping have gained importance for predicting HBV disease progression, have been employed for assessing infectivity, for treatment monitoring and for detecting the emergence of drug resistance. Twenty-nine Brazilian patients with suspected chronic hepatitis B were studied, using real time PCR for viral load determination and direct DNA sequencing for the genotyping. The serology revealed chronic HBV infection in 22 samples. The HBV-DNA was positive in 68% samples (15/22). The phylogenetic analysis disclosed that eleven patients were infected with HBV genotype A, two with genotype F and two with genotype D. Thus, the genotype A was the most prevalent in our study.
INTRODUCTION
Hepatitis B virus (HBV) infects 400 million people worldwide 8, 9 , with a particularly high prevalence in Asia and Africa. HBV is the most common cause of liver disease worldwide 14, 22 being a global health problem 7 . Some patients may be affected only mildly 9, 22 , while other patients may evolve to cirrhosis, hepatocellular carcinoma 8 , and death from chronic hepatitis B 19 .
HBV molecular virology and immunology were found to be more complex than initially thought, whereas the selection of precore HBV mutants was showed to be largely determined by the HBV genotype 5 . Several studies found an association between variants of the virus and genetic variations found in the host. However, only recently the impact of natural variability of the virus on the clinical course of disease has become the focus of research 17 .
In Latin America there are more than 140,000 acute cases of hepatitis B per year and about 6.6 to 12 million people are chronic HBV carriers. More than 65% of these cases live in South America, where about 100,000 cases of acute hepatitis B occur annually 2 . In Brazil, there are more than 75,000 acute cases per year and HBsAg prevalence increases from South to North: 1% in the Southern and Central Western regions; 2% in the Southeastern region; 2.5% in the Northeastern region, and 8% in the Northern region. However, moderate to elevated HBsAg prevalence has been detected in candidate blood donors from the Southern states Santa Catarina (4.3%) and Paraná (8.3%) 2 .
HBV genotypes have a distinct geographical distribution 11, 19 . There are eight major HBV genotypes (A to H) prevailing in different parts of the world. Genotyping A is pandemic 8, 20 , B and C are commonly found in east Asia, and the latter has been associated with an increased risk of hepatocellular carcinoma 19 . Genotype D has been found worldwide with highest prevalence in Mediterranean area, Middle East and South Asia, particularly in India. The genotyping E is found in sub-Saharan Africa, F in South and Central America, G in France and in USA 1, 12 . Genotype H so far seems to be restricted to Northern Latin America 12 . Coinfection with several HBV genotypes seems to be rare, below 5% 19 .
In Brazil, the genotype A is the most prevalent and the genotypes B, C, D, and F have already been reported. Their distribution varies among Brazilian regions suggesting an influence of the immigration pattern for each region 18 .
The objective of the present study was to evaluate the serum viral load and the virus genotype in chronically infected Hepatitis B virus (HBV) patients. The phylogenetic analysis disclosed that eleven patients were infected with HBV genotype A, two with genotype F and two with genotype D. Therefore, the genotype A was the most prevalent in our study in São Paulo city. 
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MATERIALS AND METHODS
Blood samples: A total of 29 blood samples of patients with suspected chronic hepatitis B were collected. The serum was collected before the beginning of the antiviral treatment and stored at -70 °C. Age, sex and risk factors were obtained for infection with HBV and the time of infection estimated for patients with risk factors for blood transfusion and vertical transmission. The study protocol was approved by the Ethical Committee of the Institute of Infectious Diseases "Emílio Ribas" and written informed consent was obtained from all patients.
DNA extraction, Viral load determination, Nested-PCR and Sequencing: To detect hepatitis B viral DNA in the serum, HBV-DNA was isolated from 200 µL of serum using extraction method QIAamp DNA Blood Mini Kit (Qiagen, Germany) according to the manufacturers' protocol. Conventional PCR was carried out to amplify a 239 bp of DNA fragment.
HBV-DNA was quantified by TaqMan technology based real time PCR (quantitative polymerase chain reaction (qPCR)) as described by GARSON et al. 4 , including albumen as positive control. Reactions were analyzed by Bio-Rad iCycler IQ Real Time PCR (Hercules, CA, USA). To test the performance of our primers and probes in real time PCR, we used 10 6 , 10 5 , 10 4 , 10 3 , 10 2 , and 10 copies of HBV-DNA. Our results showed that amplification performance was good for all reactions.
Positive samples were amplified by conventional PCR for posterior genotyping. Polymerase chain reaction (PCR) and nested-PCR have been described by KANEKO et al. 6 . The HBV PCR products were sequenced utilizing ABI Prism Big Dye Terminator Ready Reaction Kit version 3.0 (Applied Biosystems, Foster City, CA). Reactions were analyzed by ABI Prism 3100 Genetic Analyzer (Applied Biosystems, Foster City, CA). Sequences were validated after visual inspection and analysis using the Sequencher program version 4.0.5 (Gene Codes).
Phylogenetic analysis:
The fifteen sequences with 239 base pairs from precore region generated (Table 1) were manually aligned with 21 reference sequences from genotypes A to H. The GenBank accession numbers for the reference sequences were: AY128092, X51970, AB241114, D00329, AB010289, X04615, AY123041, AB014381, M32138, X85254, X75657, AB032431, X69798, AB036910, AF223965, AF160501, AB064310, AF405706, AY090454, AY090457, AY090460.
Phylogenetic analyses were performed using both maximum likelihood (ML) criterion and Bayesian inference. ML searches were performed using GARLI v0.951.OsX-GUI 21 under an assumed general time-reversible (GTR) model with rates estimated from the data. Three independently runs were performed. Each run gave identical topologies and similar likelihood scores. The Bayesian analysis was performed with MrBayes 16 using a GTR + invariant (ι) and gamma (Γ 4 ). The MCMC search was run for 2 x 10 6 generations with trees sampled every 100 th generation (with a burn-in of 10%). The final tree presented is the maximum clade credibility tree inferred using TreeAnnotator v1.4.7 (available from http://beast.bio.ed.ac.uk) from the 1800 trees estimated by MrBayes.
RESULTS
A total of twenty-nine Brazilian patients with suspected chronic hepatitis B were studied. The serology revealed that 22 had HBsAg detection after six months from the first positive sample. HBV-DNA was positive in 68% samples (15/22) , eight women and seven men, with a mean age of 42 years (range 31-51) and the HBV genotype was determined in 15 of 15 samples which presented detectable viral load (Table 1) . In seven cases, the HBV-DNA viral load was undetectable by quantitative PCR; the cause of no amplification was low DNA serum viral. 
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The phylogenetic analysis disclosed that eleven patients were infected with HBV genotype A (73.3%), two with genotype F (13.3%) and two with genotype D (13.3%), as shown on Fig. 1 . Therefore, the genotype A was the most prevalent in our study in São Paulo city.
DISCUSSION
HBV genotyping among chronic carriers was studied in São Paulo city. This small sample had a mean age of 42 years, and was made up predominantly of females. In the city of Salvador, Brazil, the majority of the cases corresponded to males, with a similar distribution age (30 to 40 years) 15 . Viral load was detected in fifteen samples, and two patients had viral load that were above the upper limit of detection. To our knowledge, this is the first study to describe HBV viral load done with Brazilian subjects.
Clinical studies have shown a high rate of HBV-DNA in chronic cases 7 . Quantitative HBV-DNA assays and HBV genotyping have gained importance for predicting HBV disease progression, employed for assessing infectivity, for treatment monitoring and for detecting the emergence of drug resistance 4, 19 . A study showed that viral load is the major determinant of the risk of liver cirrhosis, hepatocellular carcinoma and death in chronic hepatitis B patients 19 .
To our knowledge, this is the first time that HBV genotypes from patients living in São Paulo were typed. The genotypes showed a distinct and well-defined geographic distribution. In our study, genotype A was the most prevalent, but other subtypes were also typed, such as F and D. This distribution was similar to that found in Rio de Janeiro and Salvador, for example 13, 15 . The higher prevalence of HBV genotype A might reflect the ethnic background of the Brazilian population, with its strong miscigenation 15 . The white population of São Paulo is descendant of Portuguese and other Europeans, predominantly Italians. Other studies have also shown that genotype A is most commonly found in North America, Africa and Northwestern Europe 15 and is the most prevalent in Brazil followed by genotypes B, C, D and F 18 as already documented among most other groups of chronic carriers, excluding hemodialysis patients 3 .
In the Amazonian region, only genotype F was found among the native Brazilian tribes who have not had contact with whites, while genotype A was found among tribes with frequent contacts 13 . In a study 
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from MAYERAT et al. 10 , it was suggested that the infection by HBV genotype A could be more frequently associated with chronic infection than genotype D. HBV genotype D has a universal distribution, however it seems to be more prevalent in Southern Europe, Middle East, Northern Africa and India 15 .
Finally, for the first time the HBV genotype was performed in samples from patients living in São Paulo city. The HBV-DNA viral load was performed for clinical samples to follow up the patients. Viral load is a major marker of disease progression and for treatment guidelines. Summing up, quantitative real time PCR was a simple, sensitive, specific and reproducible assay for the measurement of HBV viral load in serum samples.
RESUMO
Distribuição dos genótipos do vírus da hepatite B e níveis de carga viral em pacientes brasileiros cronicamente infectados na cidade de São Paulo
O objetivo do presente estudo foi avaliar a carga viral no soro de pacientes cronicamente infectados pelo vírus da Hepatite B (HBV) e investigar a distribuição de genótipos HBV na cidade de São Paulo. PCR quantitativo do HBV e genotipagem ganharam importância para a previsão de progressão da doença, empregada para avaliar a infectividade, para tratamento e acompanhamento e para detectar o aparecimento de resistência aos anti-retrovirais. Vinte e nove pacientes brasileiros com suspeita de hepatite B crônica foram estudados, utilizando PCR em tempo real para a determinação da carga viral e seqüenciamento direto para determinação do genótipo. A sorologia revelou que 22 estavam, de fato, cronicamente infectados pelo HBV. O HBV-DNA foi positivo em 68% das amostras (15/22) . Em sete casos, HBV-DNA foi indetectável por PCR quantitativo. A análise filogenética mostra que onze pacientes foram infectados com hepatite B genótipo A, dois com genótipo F e dois com genótipo D. Desta forma, o genótipo A foi o mais prevalente em nosso estudo.
